LEADER 03452nam 2200589 450 001 9910774729203321 005 20231110214754.0 010 $a3-11-078314-2 024 7 $a10.1515/9783110783148 035 $a(CKB)5580000000395728 035 $a(NjHacI)995580000000395728 035 $a(DE-B1597)617476 035 $a(DE-B1597)9783110783148 035 $a(MiAaPQ)EBC7107809 035 $a(Au-PeEL)EBL7107809 035 $a(OCoLC)1349351818 035 $a(EXLCZ)995580000000395728 100 $a20221124d2022 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aViral Lobbying $eStrategies, Access and Influence During the COVID-19 Pandemic /$fMichele Crepaz [and three others] 210 1$aBerlin ;$aBoston :$cDe Gruyter,$d2022. 210 4$dİ2022 215 $a1 online resource (xi, 188 pages) $cillustrations 225 0 $aViral Politics ;$vVolume 3 311 $a3-11-078305-3 320 $aIncludes bibliographical references. 327 $tFrontmatter -- $tContents -- $tFigures -- $tTables -- $tChapter 1 Viral Lobbying and the Influence Production Process -- $tChapter 2 The InterCov Project -- $tChapter 3 Issue Mobilisation -- $tChapter 4 Strategy Selection -- $tChapter 5 Access to Gatekeepers -- $tChapter 6 Lobbying Influence -- $tChapter 7 Interest Groups? Experiences with Lobbying during the Pandemic -- $tChapter 8 Trends and Biases in Viral Lobbying and their Implications -- $tAPPENDIX TO: VIRAL LOBBYING -- $tOnline Appendix -- $tChapter 3 Issue Mobilisation -- $tChapter 4 Strategy selection -- $tChapter 5 Access to Gatekeepers -- $tChapter 6 Lobbying influence -- $tChapter 7 Interest Groups? Experiences with Lobbying during the Pandemic -- $tReferences 330 $aPandemic policies have been the focus of fierce lobbying competition by different social and economic interests. In Viral Lobbying a team of expert authors from across the social and natural sciences analyse patterns in and implications of this 'viral lobbying'. Based on elite surveys and focus group interviews with selected groups, the book provides new evidence on the lobbying strategies used during the COVID 19 pandemic, as well as the resulting access to and lobbying influence on public policy. The empirical analyses reach across eight European countries (Austria, Denmark, Germany, Ireland, Italy, the Netherlands, Sweden, United Kingdom), as well as the EU-level. In particular, the book draws on responses from approximately 1,600 interest organisations in two waves of a cross-country survey (in 2020 and 2021, respectively). This quantitative data is supplemented by qualitative evidence from a series of 12 focus groups with organised interests in Ireland, Denmark and the Netherlands conducted in spring 2021. 410 0$aViral Politics 517 $aViral Lobbying 606 $aLobbying 606 $aMedical policy 606 $aCOVID-19 (Disease) 610 $aLobbying. 610 $aPandemic Politics. 610 $aPublic Policy. 610 $aStakeholder Consultation. 615 0$aLobbying. 615 0$aMedical policy. 615 0$aCOVID-19 (Disease) 676 $a324.4 700 $aCrepaz$b Michele$01264955 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910774729203321 996 $aViral Lobbying$92966049 997 $aUNINA